DePrince Race & Zollo Inc (DRZ)’s Pfizer PFE Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-472,570	Closed	-$19.6M	–	234
2018 Q4	$19.6M	Sell	472,570 -147,981	-24%	-$6.14M	0.57%	76
2018 Q3	$25.9M	Sell	620,551 -113,545	-15%	-$4.37M	0.58%	71
2018 Q2	$25.3M	Sell	734,096 -12,679	-2%	-$433K	0.58%	64
2018 Q1	$25.1M	Buy	746,775 +30,349	+4%	+$1.04M	0.59%	72
2017 Q4	$24.6M	Sell	716,426 -57,243	-7%	-$1.95M	0.55%	81
2017 Q3	$26.2M	Buy	+773,669	New	+$24.9M	0.59%	71
2015 Q2	–	Sell	-2,737,436	Closed	-$90.4M	–	285
2015 Q1	$90.4M	Sell	2,737,436 -305,473	-10%	-$9.71M	1.27%	5
2014 Q4	$89.9M	Sell	3,042,909 -110,870	-4%	-$3.18M	1.23%	7
2014 Q3	$88.5M	Buy	+3,153,779	New	+$88.5M	1.2%	9

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s PFE Position: Q1 2019 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Pfizer (PFE) in Q1 2019, closing a stake of 472,570 shares — an estimated $19.6M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in PFE in Q3 2014 and held it in 9 quarters. The position peaked at $90.4M in Q1 2015. 2,392 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

DePrince Race & Zollo Inc (DRZ) reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
DePrince Race & Zollo Inc (DRZ) sold 472,570 Pfizer shares in Q1 2019, an estimated $19.6M.
DePrince Race & Zollo Inc (DRZ) first reported a position in Pfizer in Q3 2014 and held it in 9 quarters.
DePrince Race & Zollo Inc (DRZ)'s Pfizer position peaked at $90.4M in Q1 2015.
2,392 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2019, filed 18 Apr 2019.